Marie C. Bradley, PhD, MScPH, MPharm

Pharmcoepidemiologist
Division of Epidemiology, Office of Surveillance and epidemiology,Center for Drug Evaluation and Research, US Food and Drug Administration

Presentation(s):

• OP-27E - Categorization of COVID-19 Severity to Determine Mortality Risk

  Tuesday, August 24, 2021
  1:45 PM – 3:30 PM US Eastern Time

• L-3D - A New Analytic Tool for Interrupted Times Series Analysis to Assess the Impact of FDA Regulatory Actions

  Tuesday, August 24, 2021
  6:45 PM – 7:45 PM US Eastern Time